等待开盘 08-01 09:30:00 美东时间
+5.170
+4.13%
System qualified for emerging PMIC device application requiring advanced 15 MeV implant capability BEVERLY, Mass., July 28, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a ...
07-28 20:00
Crinetics Pharmaceuticals涨96.69%;费哲金融服务涨4.46%;库珀医疗涨3.64%
07-07 15:01
今日重点评级关注:摩根士丹利:维持杜邦"标配"评级,目标价从52美元升至156美元;蒙特利尔银行:维持Taysha Gene Therapies"跑赢大市"评级,目标价从10美元升至14美元
06-24 14:08
B of A Securities analyst Duksan Jang maintains Axcelis Technologies (NASDAQ:ACLS) with a Underperform and raises the price target from $130 to $156.
06-23 20:25
Shares of semiconductor and chip companies are trading lower as robust U.S. pay...
06-06 02:56
BEVERLY, Mass., May 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced th...
05-12 20:00
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Axcelis Technologies 2026年第一季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 总营收1.99亿美元,包含500万美元的一次性客户和解费用影响 - 系统营收1.26亿美元,受和解费用影响 - CS&I(客户支持与集成)营收7300万美元 **盈利能力:** - 毛利率40.7%,低于41%的预期,主要受客户和解费用影响约70个基点 - 营业利润率11.7% - 调整后EBITDA为2770万美元,利润率13.9% - 每股收益0.72美元(摊薄后),客户和解费用影响每股收益0.09美
05-08 12:01
华盛资讯5月8日讯,亚舍立科技公布2026财年Q1业绩,公司Q1营收1.99亿美元,同比增长3.3%,归母净利润0.09亿美元,同比下滑67.8%。
05-08 07:48
Shares of semiconductor and chip companies are trading higher amid overall mark...
05-07 03:55
BEVERLY, Mass., May 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced tod...
05-06 20:00